Marché des tests de dispositifs médicaux en Amérique du Nord – Tendances et prévisions du secteur jusqu’en 2030

Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché des tests de dispositifs médicaux en Amérique du Nord – Tendances et prévisions du secteur jusqu’en 2030

  • Healthcare
  • Publish Reports
  • Jun 2023
  • North America
  • 350 Pages
  • Nombre de tableaux : 35
  • Nombre de figures : 43

North America Medical Device Testing Market

Taille du marché en milliards USD

TCAC :  % Diagram

Diagram Période de prévision
2024 –2030
Diagram Taille du marché (année de référence)
MILLIONS DE DOLLARS AMÉRICAINS
Diagram Taille du marché (année de prévision)
Dollars américains 4,904.16
Diagram TCAC
%
DiagramPrincipaux acteurs du marché
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5 < /li>

Marché des tests de dispositifs médicaux en Amérique du Nord, par type de service (services de test, services d'inspection et services de certification), type de test (tests physiques, tests chimiques/biologiques, tests de cybersécurité, tests de microbiologie et de stérilité, et autres), phase (préclinique et clinique), type d'approvisionnement (interne et externalisé), classe de dispositif (classe I, classe II et classe III), produit (dispositif médical implantable actif, dispositif médical actif, dispositif médical non actif, dispositif médical de diagnostic in vitro, dispositif médical ophtalmique, dispositif médical orthopédique et dentaire, dispositif médical vasculaire, et autres) - Tendances et prévisions de l'industrie jusqu'en 2030.  

Marché des tests de dispositifs médicaux en Amérique du Nord

Analyse et perspectives du marché des tests de dispositifs médicaux en Amérique du Nord

Les dispositifs médicaux sont essentiels car ils ont un impact direct sur la vie humaine. Les fabricants de dispositifs médicaux suivent les meilleures pratiques en matière de tests, de vérification et de validation pour garantir la qualité et la fiabilité des équipements médicaux afin de fournir des services de santé sûrs et efficaces aux patients. Il existe un aperçu de haut niveau de la mise en œuvre des stratégies de test des dispositifs médicaux. De nombreux organismes de réglementation et de conformité régissent les dispositifs médicaux. D'autre part, les utilisateurs finaux attendent des performances, une efficacité et une sécurité exceptionnelles de l'appareil qu'ils utilisent. Cela oblige les fabricants de dispositifs médicaux à créer et à déployer des stratégies de test qui fonctionnent tout au long du cycle de développement, du concept et de la conception à la production.

Marché des tests de dispositifs médicaux en Amérique du Nord

Marché des tests de dispositifs médicaux en Amérique du Nord

Le besoin croissant de vérification et de validation des dispositifs médicaux à l'échelle mondiale a stimulé la croissance du marché. Certains des principaux acteurs du marché se concentrent fortement sur divers lancements et approbations de services au cours de cette période cruciale. En outre, la demande croissante de tests in vitro contribue également à la demande croissante de tests de dispositifs médicaux. Le marché nord-américain des tests de dispositifs médicaux connaît une croissance au cours de l'année de prévision en raison de l'augmentation du nombre d'acteurs du marché et de la disponibilité de services avancés.

Toutefois, les obstacles au développement local des dispositifs médicaux et le coût élevé des dispositifs médicaux pourraient entraver la croissance du marché des tests de dispositifs médicaux en Amérique du Nord au cours de la période de prévision.

Data Bridge Market Research analyse que le marché nord-américain des tests de dispositifs médicaux devrait atteindre la valeur de 4 904,16 millions USD d'ici 2030, à un TCAC de 12,0 % au cours de la période de prévision.  

Rapport métrique

Détails

Période de prévision

2023 à 2030

Année de base

2022

Années historiques

2021 (personnalisable de 2015 à 2020)

Unités quantitatives

Chiffre d'affaires en millions USD

Segments couverts

Service Type (Testing Services, Inspection Service and Certification Services), Testing Type (Physical Testing, Chemical/Biological Testing, Cybersecurity Testing, Microbiology Testing and Sterility Testing, and Others), Phase (Preclinical and Clinical), Sourcing Type (In-House and Outsourced), Device Class (Class I, Class II and Class III), Product (Active Implant Medical Device, Active Medical Device, Non-active Medical Device, In vitro Diagnostics Medical Device, Opthalmic Medical Device, Orthopedic and Dental Medical Device, Vascular Medical Device, and Others)

Countries Covered

U.S., Canada, and Mexico  

Market Players Covered

Intertek Group plc, SGS SA, Bureau Veritas, TUV SUD, TUV Rheinland, Pace, Charles River Laboratories., Biomedical Device Labs, UL LLC, North American Science Associates, LLC, WuXi AppTec, NSF., Laboratory Corporation of America Holdings, Eurofins Scientific, NELSON LABORATORIES, LLC- A SOTERA HEALTH COMPANY, Gateway Analytical., Element Materials Technology, Hohenstein, Cigniti, Q Laboratories, and IMR Test Labs among others  

Market Definition

Medical device testing is the process of demonstrating that the device is reliably and safely performed in use. In new product development, extensive design validation testing is applied. This includes performance testing, toxicity, chemical analysis, and sometimes human factors or even clinical testing. Ongoing quality assurance testing is generally more limited. This usually includes dimensional checks, some functional tests, and packaging verification. Various types of medical testing services are available there in the market, such as inspection services, certification services, and others.

North America Medical Device Testing Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:    

Drivers

  • Rising Need for Verification Validation of Medical Devices

Medical device testing is the process of demonstrating that the device will reliably and safely perform diagnosis and treatment. The demand for medical devices is constantly rising as there is a high prevalence of various diseases seen among various regions across the globe.

The methods of verification and validation are widespread and extensively being used in the healthcare industry. In general, verification is the developmental phase of a product if it complies with the specified requirements, whereas validation checks if the intended use has been met and, thus, usability specifics are fulfilled. The most common types of verification and validation for medical devices are design, process, and software verification and validation.

Medical devices are also becoming smaller and more complex in design using advanced, engineered plastics. This makes the process of validation and verification (V&V) all the more important. The results in better repeatability, fewer mistakes, less rework and redesign, faster time to market, improved competitiveness, and lower production costs. Additionally, increasing standards and regulations about medical device validation and verification services are anticipated to drive the growth of the medical device testing market.

  • Increasing Demand for In-Vitro Tests

In vitro diagnostics (IVD) are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.

In-vitro tests are used in various disease detections, such as HIV infections, malaria, and hepatitis, among others. The prevalence of such diseases is rapidly increasing across the globe, which leads to the increasing demand for in-vitro tests and various medical devices. As medical devices have become widely available for various diseases due to the rapid manufacturing of medical testing companies, it is a major factor driving the growth of the market.

Marché des tests de dispositifs médicaux en Amérique du Nord

Opportunities

  • Rise in Healthcare Expenditure

Healthcare expenditure has increased worldwide as disposable income in various countries is increasing. Moreover, to accomplish the population requirements, government bodies and healthcare organizations are taking the initiative to accelerate healthcare expenditure. The rise in healthcare expenditure simultaneously helps healthcare settings to improve their treatment facilities for various disorders in the countries.

Growing healthcare expenditure is also beneficial for further economic growth and healthcare sector growth, and it is primarily fruitful as it significantly affects the development of better and more advanced medical products. Therefore, the surge in healthcare expenditure is a greater opportunity for the North America medical device testing market growth.

  • Development in Ai And Iot in Various Medical Devices

Artificial intelligence (AI) is a powerful and ever-emerging technology that has the potential to improve capabilities across a multitude of industries. Medical devices with artificial intelligence hold the promise of revolutionizing the healthcare industry, helping medical professionals more accurately and effectively diagnose and treat their patients and improve their overall care. Along with its benefits, medical device artificial intelligence also faces challenges, including the need for regulation to keep up with technological advancement.

Thus, the North America medical device testing market is witnessing a series of developments in drug-device combination, personalized medicine, and elevated adaption of various portable and wearable medical devices. Implementing technological advancements such as IoT and Artificial Intelligence in various devices is a key growth parameter for the global medical device testing service market, creating a huge opportunity.

Challenges/ Restraints

  • High Competition in Medical Technology Industry

Many global companies face significant competition from many companies, from large medical device manufacturing companies with multiple product lines. Several players have wide financial and marketing resources than others. The common competition in healthcare involves various elements such as price, quality, convenience, and brand name. Competition can also be based on new technologies and innovation. In general, competition reduces inefficiencies that would otherwise yield high costs of output, which are eventually passed to consumers by high costs of health care and delivery. Products on the market are marketed based on product specifications, product consistency, supply, and price. Consumers, however, benefit from competition that offers rewards for continuing product upgrades and facilitates a higher degree of service efficiency among industry participants. The company’s ability to compete in the market is also impacted by changes in consumer preferences and requirements, such as the growing demand for more eco-friendly medical devices that can be easily dumped without harming the environment and the products incorporated with digital capabilities. This shows high competition in the market, which is a major challenge for the market.

  • Barriers to the Local Development of Medical Devices

While promoting standards and control of medical devices is essential, excessive regulations, particularly in the domestic context, can also act as a barrier to local innovation of these devices.

It can potentially hinder domestic innovation by subjecting new technologies to a lengthy and expensive licensing procedure, subsequently increasing the cost and the time that local manufacturers have to spend in addition to the manufacturing cost of the medical equipment. A few products, which are of significant value to low-income countries, may be removed from the market due to the perceived risks associated with their use.

Various factors, such as licensing procedures, the cost of the medical equipment, and various other regulations for the production of medical devices faced by local development manufacturers, all these causes may hamper the growth of the medical device testing market.

Recent Developments

  • In April 2021, TÜV SÜD announced that it had presented itself at Medtec LIVE to exhibit its ability to be a one-stop shop for medical device testing. The company’s services cover testing in electrical and functional safety, cyber security and software, EMC, and biocompatibility. The experts from TÜV SÜD featured in the program of the online trade show and congress with various talks, a live hack, and an elevator pitch.
  • In June 2020, Intertek announced the expansion of its personal protective equipment services to include precertification testing of N95 respirators to requirements set by the National Institute for Occupational Safety and Health (NIOSH). The new services are the result of the successful accreditation to NIOSH Standard Test Protocols, in accordance with ISO 17025. With these new services, Intertek expands upon its solutions and resources to support customers and the global community during the COVID-19 pandemic.

North America medical device testing market Scope

North America medical device testing market is segmented into service type, testing type, phase, sourcing type, device class, and product. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.  

Service Type

  • Testing Services
  • Inspection Services
  • Certification Services

On the basis of service type, the North America medical device testing market is segmented into testing services, inspection services, and certification services.

Testing Type

  • Physical Testing
  • Chemical/Biological Testing
  • Cybersecurity Testing
  • Microbiology And Sterility Testing
  • Others

On the basis of testing type, the North America medical device testing market is segmented into physical testing, chemical/biological testing, cybersecurity testing, microbiology and sterility testing, and others.  

Phase

  • Preclinical
  • Clinical

On the basis of phase, the North America medical device testing market is segmented into preclinical and clinical.

Sourcing Type

  • In-House
  • Outsourced

On the basis of sourcing type, the North America medical device testing market is segmented into in-house and outsourced

Device Class

  • Class I
  • Class II
  • Class III

On the basis of device class, the North America medical device testing market is segmented into class I, class II, and class III.

Product

  • Active Implant Medical Device
  • Active Medical Device
  • Non-Active Medical Device
  • In Vitro Diagnostic Medical Device
  • Ophthalmic Medical Device
  • Orthopedic and Dental Medical Device
  • Vascular Medical Device
  • Others

On the basis of product, the North America medical device testing market is segmented into active implant medical device, active medical device, non-active medical device, in vitro diagnostics medical device, opthalmic medical device, orthopedic and dental medical device, vascular medical device, and others.

Marché des tests de dispositifs médicaux

North America Medical Device Testing Market Regional Analysis/Insights

Le marché nord-américain des tests de dispositifs médicaux est segmenté en type de service, type de test, phase, type d'approvisionnement, classe d'appareil et produit.

Les pays couverts dans ce rapport de marché sont les États-Unis, le Canada et le Mexique.

Les États-Unis devraient dominer le marché en raison de la forte prévalence des tests de dispositifs médicaux dans la région et de l’augmentation des dépenses de santé.

La section par pays du rapport fournit également des facteurs individuels ayant un impact sur le marché et des changements dans la réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que les nouvelles ventes, les ventes de remplacement, la démographie du pays, les actes réglementaires et les tarifs d'importation et d'exportation sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario du marché pour les différents pays. En outre, la présence et la disponibilité des marques européennes et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, ainsi que l'impact des canaux de vente sont pris en compte lors de l'analyse prévisionnelle des données nationales.

Analyse du paysage concurrentiel et des parts de marché des tests de dispositifs médicaux en Amérique du Nord

Le paysage concurrentiel du marché des tests de dispositifs médicaux en Amérique du Nord fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements en R&D, les nouvelles initiatives du marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les pipelines d'essais de produits, les approbations de produits, les brevets, la largeur et la portée du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation de l'entreprise vers le marché des tests de dispositifs médicaux en Amérique du Nord.

Français Certains des principaux acteurs opérant sur le marché des tests de dispositifs médicaux en Amérique du Nord sont Intertek Group plc, SGS SA, Bureau Veritas, TUV SUD, TUV Rheinland, Pace, Charles River Laboratories., Biomedical Device Labs, UL LLC, North American Science Associates, LLC, WuXi AppTec, NSF., Laboratory Corporation of America Holdings, Eurofins Scientific, NELSON LABORATORIES, LLC- A SOTERA HEALTH COMPANY, Gateway Analytical., Element Materials Technology, Hohenstein, Cigniti, Q Laboratories et IMR Test Labs, entre autres.


SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA MEDICAL DEVICE TESTING MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 SERVICE TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET TESTING TYPE COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES

5 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING NEED FOR VERIFICATION VALIDATION OF MEDICAL DEVICES

6.1.2 INCREASING DEMAND FOR IN-VITRO TESTS

6.1.3 ESCALATION IN INNOVATION AND TECHNOLOGIES

6.2 RESTRAINTS

6.2.1 BARRIERS TO THE LOCAL DEVELOPMENT OF MEDICAL DEVICES

6.2.2 HIGH COST OF MEDICAL DEVICES

6.3 OPPORTUNITIES

6.3.1 RISE IN HEALTHCARE EXPENDITURE

6.3.2 DEVELOPMENT IN AI AND IOT IN VARIOUS MEDICAL DEVICES

6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS

6.4 CHALLENGES

6.4.1 HIGH COMPETITION IN MEDICAL TECHNOLOGY INDUSTRY

6.4.2 LONG LEAD TIME FOR OVERSEAS QUALIFICATION

7 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE

7.1 OVERVIEW

7.2 TESTING SERVICES

7.3 INSPECTION SERVICES

7.4 CERTIFICATION SERVICES

8 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE

8.1 OVERVIEW

8.2 CHEMICAL/BIOLOGICAL TESTING

8.3 MICROBIOLOGY AND STERILITY TESTING

8.3.1 STERILITY TEST & VALIDATION

8.3.2 BIO BURDEN DETERMINATION

8.3.3 ANTIMICROBIAL ACTIVITY TESTING

8.3.4 PYROGEN & ENDOTOXIN TESTING

8.3.5 OTHERS

8.4 PHYSICAL TESTING

8.4.1 ELECTRICAL SAFETY TESTING

8.4.2 FUNCTIONAL SAFETY TESTING

8.4.3 EMC TESTING

8.4.4 ENVIRONMENTAL TESTING

8.4.5 OTHERS

8.5 CYBERSECURITY TESTING

8.6 OTHERS

9 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PHASE

9.1 OVERVIEW

9.2 PRECLINICAL

9.3 CLINICAL

10 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE

10.1 OVERVIEW

10.2 OUTSOURCED

10.3 IN-HOUSE

11 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS

11.1 OVERVIEW

11.2 CLASS I

11.3 CLASS III

11.4 CLASS II

12 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PRODUCT

12.1 OVERVIEW

12.2 NON-ACTIVE MEDICAL DEVICE

12.3 ORTHOPEDIC AND DENTAL MEDICAL DEVICE

12.4 ACTIVE IMPLANT MEDICAL DEVICE

12.5 VASCULAR MEDICAL DEVICE

12.6 ACTIVE MEDICAL DEVICE

12.7 IN-VITRO DIAGNOSTICS MEDICAL DEVICE

12.8 OPTHALMIC MEDICAL DEVICE

12.9 OTHERS

13 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY GEOGRAPHY

13.1 NORTH AMERICA

13.1.1 U.S.

13.1.2 CANADA

13.1.3 MEXICO

14 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 LABORATORY CORPORATION OF AMERICA HOLDINGS

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 CHARLES RIVER LABORATORIES.

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 TUV SUD

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 WUXI APPTEC

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENTS

16.5 SGS SA

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENTS

16.6 NORTH AMERICAN SCIENCE ASSOCIATES, LLC

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENTS

16.7 HOHENSTEIN

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENTS

16.8 BIOMEDICAL DEVICE LABS

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENTS

16.9 BUREAU VERITAS

16.9.1 COMPANY SNAPSHOT

16.9.2 REVENUE ANALYSIS

16.9.3 PRODUCT PORTFOLIO

16.9.4 RECENT DEVELOPMENTS

16.1 CIGNITI

16.10.1 COMPANY SNAPSHOT

16.10.2 REVENUE ANALYSIS

16.10.3 PRODUCT PORTFOLIO

16.10.4 RECENT DEVELOPMENTS

16.11 ELEMENT MATERIALS TECHNOLOGY

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENTS

16.12 EUROFINS SCIENTIFIC

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.4 RECENT DEVELOPMENTS

16.13 GATEWAY ANALYTICAL.

16.13.1 COMPANY SNAPSHOT

16.13.2 PRODUCT PORTFOLIO

16.13.3 RECENT DEVELOPMENTS

16.14 IMR TEST LABS

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENTS

16.15 INTERTEK GROUP PLC

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCT PORTFOLIO

16.15.4 RECENT DEVELOPMENTS

16.16 NELSON LABORATORIES, LLC- A SOTERA HEALTH COMPANY

16.16.1 COMPANY SNAPSHOT

16.16.2 PRODUCT PORTFOLIO

16.16.3 RECENT DEVELOPMENTS

16.17 NSF.

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 PACE

16.18.1 COMPANY SNAPSHOT

16.18.2 PRODUCT PORTFOLIO

16.18.3 RECENT DEVELOPMENTS

16.19 Q LABORATORIES

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 TUV RHEINLAND

16.20.1 COMPANY SNAPSHOT

16.20.2 REVENUE ANALYSIS

16.20.3 PRODUCT PORTFOLIO

16.20.4 RECENT DEVELOPMENTS

16.21 UL LLC

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

Liste des tableaux

TABLE 1 FDA REGULATIONS BASED ON DEVICES TYPE

TABLE 2 PRICES OF ESSENTIAL MEDICAL DEVICES

TABLE 3 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 4 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 5 NORTH AMERICA MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 6 NORTH AMERICA PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 7 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PHASE, 2021-2030 (USD MILLION)

TABLE 8 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2021-2030 (USD MILLION)

TABLE 9 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2021-2030 (USD MILLION)

TABLE 10 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 11 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 12 U.S. MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 13 U.S. MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 14 U.S. MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 15 U.S. PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 16 U.S. MEDICAL DEVICE TESTING MARKET, BY PHASE, 2021-2030 (USD MILLION)

TABLE 17 U.S. MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2021-2030 (USD MILLION)

TABLE 18 U.S. MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2021-2030 (USD MILLION)

TABLE 19 U.S. MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 20 CANADA MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 21 CANADA MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 22 CANADA MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 23 CANADA PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 24 CANADA MEDICAL DEVICE TESTING MARKET, BY PHASE, 2021-2030 (USD MILLION)

TABLE 25 CANADA MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2021-2030 (USD MILLION)

TABLE 26 CANADA MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2021-2030 (USD MILLION)

TABLE 27 CANADA MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 28 MEXICO MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 29 MEXICO MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 30 MEXICO MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 31 MEXICO PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 32 MEXICO MEDICAL DEVICE TESTING MARKET, BY PHASE, 2021-2030 (USD MILLION)

TABLE 33 MEXICO MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2021-2030 (USD MILLION)

TABLE 34 MEXICO MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2021-2030 (USD MILLION)

TABLE 35 MEXICO MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

Liste des figures

FIGURE 1 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: MARKET TESTING TYPE COVERAGE GRID

FIGURE 9 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: SEGMENTATION

FIGURE 11 INCREASING DEMAND FOR IN-VITRO TESTS AND DEVELOPMENT IN AI AND IOT IN VARIOUS MEDICAL DEVICES ARE EXPECTED TO DRIVE THE NORTH AMERICA MEDICAL DEVICE TESTING MARKET IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 12 TESTING SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA MEDICAL DEVICE TESTING MARKET IN 2023 & 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL MEDICAL DEVICE TESTING MARKET

FIGURE 14 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, 2022

FIGURE 15 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, 2023-2030 (USD MILLION)

FIGURE 16 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, CAGR (2023-2030)

FIGURE 17 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, LIFELINE CURVE

FIGURE 18 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, 2022

FIGURE 19 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, 2023-2030 (USD MILLION)

FIGURE 20 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, CAGR (2023-2030)

FIGURE 21 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, LIFELINE CURVE

FIGURE 22 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, 2022

FIGURE 23 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, 2023-2030 (USD MILLION)

FIGURE 24 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, CAGR (2023-2030)

FIGURE 25 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, LIFELINE CURVE

FIGURE 26 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, 2022

FIGURE 27 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, 2023-2030 (USD MILLION)

FIGURE 28 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, CAGR (2023-2030)

FIGURE 29 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, LIFELINE CURVE

FIGURE 30 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, 2022

FIGURE 31 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, 2023-2030 (USD MILLION)

FIGURE 32 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, CAGR (2023-2030)

FIGURE 33 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, LIFELINE CURVE

FIGURE 34 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, 2022

FIGURE 35 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 36 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 37 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 38 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: SNAPSHOT (2022)

FIGURE 39 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY COUNTRY (2022)

FIGURE 40 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY COUNTRY (2023 & 2030)

FIGURE 41 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY COUNTRY (2023 & 2030)

FIGURE 42 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE (2023-2030)

FIGURE 43 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: COMPANY SHARE 2022 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The North America medical device testing market reaches USD 4,904.16 million by 2030, at a CAGR of 12.0%.
The countries covered in this market report are the U.S., Canada, and Mexico.
the major players operating in the North America medical device testing market are Intertek Group plc, SGS SA, Bureau Veritas, TUV SUD, TUV Rheinland, Pace, Charles River Laboratories., Biomedical Device Labs, UL LLC, North American Science Associates, LLC, WuXi AppTec, NSF., Laboratory Corporation of America Holdings, Eurofins Scientific, NELSON LABORATORIES, LLC- A SOTERA HEALTH COMPANY, Gateway Analytical., Element Materials Technology, Hohenstein, Cigniti, Q Laboratories, and IMR Test Labs among others.
North America medical device testing market is segmented into service type, testing type, phase, sourcing type, device class, and product.
The U.S. is expected to dominate the market due to the high prevalence of medical device testing in the region and the rise in healthcare expenditure.